RHOA and nasopharyngeal carcinoma: However, there is some contradictory evidence showing that RhoA inactivation promoted the migration and metastasis of triple-negative breast cancer [20] and increased tumor growth and metastasis in colorectal cancer [21], liver cancers [22], and nasopharyngeal carcinoma [13].